Search
for
Sort by
Research 631–660 of 1000+
- Supplementary Material for: Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study
- 681 Inhibition of STAT3, using Oenocarpus bataua vegetable oil, on in vitro model
- TREMendous Macrophages Inhibit Hair Growth
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- 1359 Hair growth is induced by blockade of macrophage-derived oncostatin M and downstream JAK-STAT5 signaling in hair follicle stem cells
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Tofacitinib for the treatment of lichen planopilaris: A case series
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Alopecia Areata: Current Treatments and New Directions
- Resident Memory T Cells in Autoimmune Skin Diseases
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- New and Emerging Therapies for Alopecia Areata
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Tofacitinib therapy for children with severe alopecia areata
- Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
- Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Treatment of severe alopecia areata with baricitinib
- Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman